“`html Do ‘Calming’ Dog Supplements Actually Work? Separating Evidence from Marketing By Dr. Marcus R. Holloway, DVM | Published August 2026 | Reading time: 12 minutes Dogs experience anxiety. Thunderstorms, fireworks, separation, car rides, vet visits — the triggers are real, and so is the distress. A genuine behavioral or medical problem deserves evidence-based support,…
“`html By the Editorial Team — Dog Supplement Report | Published: 2026 | Reviewed for accuracy against FDA 21 CFR 507, AAFCO guidelines, and peer-reviewed veterinary literature. A walk down any boutique pet store aisle reveals supplement bottles stamped with phrases like “Made in a Human-Grade Facility,” “Kitchen-Quality Ingredients,” and “If It’s Not Good Enough…
By the Editorial Team, Dog Supplement Report Key Takeaways The “30 Billion CFU” headline number on most soft-chew labels reflects colony-forming units at the time of manufacture — not at the point of sale, and almost never at the expiration date on the bottle. Peer-reviewed literature documents that probiotic viability in soft-chew formats drops significantly…
Key Takeaways The gut-skin axis in dogs is a real, peer-reviewed phenomenon — but the published evidence supports adjunctive benefit for atopic dermatitis, not a cure for allergies. Three mechanisms have randomized controlled trial backing in dogs: omega-3 fatty acid supplementation, certain postbiotic preparations, and selected prebiotic fibers. “Probiotic fixes allergies” claims rely on extrapolation…
Key Takeaways Strain count is a marketing number, not a clinical outcome. The human and canine literature does not show that 15 or 20 strains outperform a well-chosen 2- or 3-strain formula. The “more is better” framing exploits a consumer heuristic borrowed from CFU counts and applies it where it has no validated meaning. Strain-stacking…
Key Takeaways The “more strains = better” claim is a marketing heuristic, not a clinical finding. No peer-reviewed canine study demonstrates that 15- or 20-strain products outperform well-designed 1- or 2-strain products. Strain identity matters more than strain count. A clinically documented Lactobacillus rhamnosus strain with proven efficacy outperforms an unidentified strain on a long…
Key Takeaways Strain count alone is a weak predictor of probiotic efficacy — the published canine evidence base for multi-strain superiority is thin and inconsistent. Strain identity, dose at point of consumption, and survival through the GI tract matter far more than how many strains appear on a label. The “more strains = better” narrative…
“`html This site has NO affiliate relationships with any supplement brand. We do not accept compensation for reviews, and no brand has editorial input into our reporting. Investigations are funded solely by site display advertising. — Editorial Notice Key Takeaways The “senior dog” supplement market is one of the fastest-growing segments in pet wellness, and…
Key Takeaways The label claim “30 Billion CFU” is a manufacturing-time figure. Actual viability at the point a consumer opens the package can be substantially lower. Soft chew matrices present specific, well-documented challenges to probiotic survival: moisture activity, heat during extrusion, and lipid oxidation. No publicly available third-party stability study for the Boops soft chew…
In July 2022, BC Partners completed a transaction that sent ripples through the pet supplement industry: the acquisition of Zesty Paws for a reported $610 million. The deal represented one of the largest private equit…